Orionis Biosciences Appoints Dr. Giulio Draetta as Chief Strategy Officer

Orionis Biosciences, a privately held, clinical‑stage life sciences company focused on discovery, design and development of precision medicines for cancer... Read More

The post Orionis Biosciences Appoints Dr. Giulio Draetta as Chief Strategy Officer appeared first on citybiz.